Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-11-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
113年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the current and previous periods, including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and total equity. The data is presented for the first three quarters of the fiscal year 2024 (民國113年前3季) and the same period in the previous year. The presence of detailed financial data and accounting items indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 3495 characters, which is relatively short but contains actual financial data, so it is not a mere announcement. The content aligns with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes substantive financial data and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-11-12 Chinese
113年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the third quarter of the 113th year (which corresponds to 2024) and compares it with the same period in the previous year. It includes detailed financial data such as cash flows from operating, investing, and financing activities. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 2564 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2024-11-12 Chinese
113年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the third quarter of the 113th year (likely referring to a fiscal year in the Taiwanese calendar system), with detailed financial figures such as revenue, costs, expenses, and net income. It includes quarterly and year-to-date data, which is typical of an interim or quarterly financial report. The document length is 3424 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. There is no indication that this is an annual report or a simple earnings release summary; rather, it provides detailed financial statements for a specific interim period. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2024-11-12 Chinese
113年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items. The presence of actual financial figures and accounting details for a quarterly period (third quarter of year 113 in the ROC calendar, corresponding to 2024 Q3) indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 4016 characters, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2024-11-12 Chinese
公告本公司董事會通過113年第三季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1760 寶齡富錦) reporting the board's approval of the consolidated financial report for the third quarter of the year 113 (Taiwan calendar, equivalent to 2024). It includes cumulative financial data from January 1 to September 30, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is short (909 characters) and appears to be a formal announcement of the approval of the quarterly financial report rather than the full report itself. It does not contain detailed financial statements or extensive analysis but summarizes key financial figures. Therefore, it fits the category of an Interim / Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year.
2024-11-12 Chinese
113年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 寶齡富錦, providing data on fund loans and guarantee information for the current and previous month. The content is very short (613 characters) and consists mainly of tabular financial data without detailed analysis or narrative. It does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure or compliance update rather than a full report. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.